Clinical Trial Update: Quality of Life in Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte Extracts [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated quality of life in patients with allergic rhinoconjunctivitis treated with dialyzable leukocyte extracts. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinoconjunctivitis

Drugs mentioned

• Dialyzable Leukocyte Extracts (dialyzable leukocyte extract)

Snippet

Sponsor: National Polytechnic Institute, Mexico | Conditions: Allergic Rhinoconjunctivitis | Phase 2 | Status: COMPLETED